Soligenix
SNGX
#10199
Rank
ยฃ9.51 M
Marketcap
ยฃ0.94
Share price
2.44%
Change (1 day)
-48.10%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.43. In 2024 the company made an earnings per share (EPS) of -ยฃ3.73 an increase over its 2023 EPS that were of -ยฃ9.48.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.76%
2024-ยฃ3.73-60.66%
2023-ยฃ9.48-83.55%
2022-ยฃ57.6113.95%
2021-ยฃ50.56-56.03%
2020-ยฃ114.9933.33%
2019-ยฃ86.24-29.41%
2018-ยฃ122.17-41.38%
2017-ยฃ208.4224.73%
2016-ยฃ167.09-69%
2015-ยฃ539.00-6.25%
2014-ยฃ574.94-50.77%
2013-ยฃ1,16875.68%
2012-ยฃ664.7768.18%
2011-ยฃ395.27-69.86%
2010-ยฃ1,312-8.75%
2009-ยฃ1,43733.33%
2008-ยฃ1,078-57.14%
2007-ยฃ2,515-46.15%
2006-ยฃ4,67144.44%
2005-ยฃ3,234-40.7%
2004-ยฃ5,454-15.62%
2003-ยฃ6,464-25.52%
2002-ยฃ8,679-80.94%
2001-ยฃ45,532160.89%
2000-ยฃ17,452-40.57%
1999-ยฃ29,365-63.84%
1998-ยฃ81,210601.73%
1997-ยฃ11,573101.7%
1996-ยฃ5,738

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.34-443.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.02-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.55-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.93-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.06-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA